Medios AG (0QB4.L)
EUR 11.94
(5.29%)
EUR 11.94
(5.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -53.89 Million EUR | 12.48% |
| 2022 | -61.58 Million EUR | 48.13% |
| 2021 | -118.72 Million EUR | -21024.73% |
| 2020 | -562 Thousand EUR | 94.01% |
| 2019 | -9.38 Million EUR | 18.92% |
| 2018 | -11.56 Million EUR | 30.66% |
| 2017 | -16.68 Million EUR | 2.38% |
| 2016 | -17.09 Million EUR | -3310.1% |
| 2015 | -501.18 Thousand EUR | -2306.43% |
| 2014 | -20.82 Thousand EUR | -147.74% |
| 2013 | -8406.86 EUR | -4554.19% |
| 2012 | -180.63 EUR | -100.15% |
| 2011 | 116.81 Thousand EUR | -40.95% |
| 2010 | 197.82 Thousand EUR | -0.09% |
| 2009 | 198 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 156.77 Million EUR | 263.8% |
| 2024 Q1 | -95.7 Million EUR | -77.59% |
| 2023 Q2 | 34.23 Million EUR | 328.32% |
| 2023 Q3 | -49.63 Million EUR | -244.97% |
| 2023 FY | -53.89 Million EUR | 12.48% |
| 2023 Q4 | -53.89 Million EUR | -8.58% |
| 2023 Q1 | -14.99 Million EUR | 75.65% |
| 2022 Q4 | -61.58 Million EUR | -52.2% |
| 2022 Q2 | -34.7 Million EUR | 37.02% |
| 2022 FY | -61.58 Million EUR | 48.13% |
| 2022 Q1 | -55.1 Million EUR | 53.59% |
| 2022 Q3 | -40.46 Million EUR | -16.58% |
| 2021 Q1 | -20.79 Million EUR | -3600.71% |
| 2021 Q3 | -28.94 Million EUR | -31.59% |
| 2021 Q4 | -118.72 Million EUR | -310.17% |
| 2021 FY | -118.72 Million EUR | -21024.73% |
| 2021 Q2 | -21.99 Million EUR | -5.76% |
| 2020 Q1 | 15.87 Million EUR | 269.18% |
| 2020 FY | -562 Thousand EUR | 94.01% |
| 2020 Q4 | -562 Thousand EUR | 99.05% |
| 2020 Q3 | -59.44 Million EUR | 11.89% |
| 2020 Q2 | -67.46 Million EUR | -525.08% |
| 2019 Q4 | -9.38 Million EUR | 0.0% |
| 2019 FY | -9.38 Million EUR | 18.92% |
| 2019 Q2 | -9.41 Million EUR | -179.46% |
| 2019 Q1 | 11.84 Million EUR | 202.43% |
| 2018 Q1 | -15.15 Million EUR | 9.18% |
| 2018 FY | -11.56 Million EUR | 30.66% |
| 2018 Q4 | -11.56 Million EUR | -0.0% |
| 2018 Q3 | -11.56 Million EUR | 23.66% |
| 2018 Q2 | -15.15 Million EUR | 0.0% |
| 2017 Q4 | -16.68 Million EUR | 0.0% |
| 2017 Q3 | -16.68 Million EUR | -147.18% |
| 2017 Q2 | -6.75 Million EUR | 0.0% |
| 2017 Q1 | -6.75 Million EUR | 60.5% |
| 2017 FY | -16.68 Million EUR | 2.38% |
| 2016 Q2 | -236.21 Thousand EUR | -119.59% |
| 2016 Q1 | 1.2 Million EUR | 340.55% |
| 2016 FY | -17.09 Million EUR | -3310.1% |
| 2016 Q4 | -17.09 Million EUR | -0.0% |
| 2016 Q3 | -17.09 Million EUR | -7135.35% |
| 2015 Q4 | -501.18 Thousand EUR | 0.0% |
| 2015 FY | -501.18 Thousand EUR | -2306.43% |
| 2015 Q2 | -22.37 Thousand EUR | 0.0% |
| 2014 Q4 | -20.82 Thousand EUR | 0.0% |
| 2014 FY | -20.82 Thousand EUR | -147.74% |
| 2014 Q2 | -3000.00 EUR | 0.0% |
| 2013 Q2 | 1000.00 EUR | 0.0% |
| 2013 Q4 | -8406.86 EUR | 0.0% |
| 2013 FY | -8406.86 EUR | -4554.19% |
| 2012 Q2 | 109 Thousand EUR | 0.0% |
| 2012 Q4 | -180.63 EUR | 0.0% |
| 2012 FY | -180.63 EUR | -100.15% |
| 2011 FY | 116.81 Thousand EUR | -40.95% |
| 2011 Q4 | 116.81 Thousand EUR | 0.0% |
| 2011 Q2 | 38 Thousand EUR | 0.0% |
| 2010 Q4 | 197.82 Thousand EUR | 0.0% |
| 2010 FY | 197.82 Thousand EUR | -0.09% |
| 2010 Q2 | 239 Thousand EUR | 0.0% |
| 2009 Q4 | 198 Thousand EUR | 0.0% |
| 2009 FY | 198 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cegedim SA | 238.49 Million EUR | 122.597% |
| Guerbet SA | 313.3 Million EUR | 117.201% |
| Nexus AG | 2.81 Million EUR | 2017.182% |
| Bastide Le Confort Médical SA | 333.35 Million EUR | 116.167% |
| Revenio Group Oyj | -2.8 Million EUR | -1824.714% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 127.023% |
| Sartorius Aktiengesellschaft | 4.89 Billion EUR | 101.1% |
| LNA Santé SA | 810.5 Million EUR | 106.649% |
| Siemens Healthineers AG | -1 Billion EUR | 94.659% |
| Equasens Société anonyme | 50.84 Million EUR | 206.001% |
| Stratec SE | 107.83 Million EUR | 149.974% |